Breaking News Bar
updated: 9/7/2012 8:03 AM

Taylor Swift to debut song for cancer victim

hello
Success - Article sent! close
  • Taylor Swift, at the MTV Video Music Awards Thursday, will debut a new song at the "Stand Up to Cancer" telethon.

      Taylor Swift, at the MTV Video Music Awards Thursday, will debut a new song at the "Stand Up to Cancer" telethon.
    Associated Press

 
Associated Press

NEW YORK -- Taylor Swift will pay tribute to a young cancer victim with a special song on Friday's "Stand Up to Cancer" telethon.

"Ronan" is dedicated to a 4-year-old boy who died last year of neuroblastoma. Swift wrote the song after reading the blog of Ronan's mother, Maya Thompson, who is credited as a co-writer.

Order Reprint Print Article
 
Interested in reusing this article?
Custom reprints are a powerful and strategic way to share your article with customers, employees and prospects.
The YGS Group provides digital and printed reprint services for Daily Herald. Complete the form to the right and a reprint consultant will contact you to discuss how you can reuse this article.
Need more information about reprints? Visit our Reprints Section for more details.

Contact information ( * required )

Success - request sent close

According to a person familiar with the show, but who asked not to be identified because they were not authorized to speak, the song has never been performed in public. After the telethon, it will be available on iTunes; all proceeds will go to cancer-related charities.

"Stand Up to Cancer" will air on all the major networks and cable channels. Besides Swift, it will feature celebrities including Tom Hanks, Julia Roberts, Gwyneth Paltrow, Justin Timberlake and more.

Share this page
Comments ()
Guidelines: Keep it civil and on topic; no profanity, vulgarity, slurs or personal attacks. People who harass others or joke about tragedies will be blocked. If a comment violates these standards or our terms of service, click the X in the upper right corner of the comment box. To find our more, read our FAQ.
    help here